Standout Papers

Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with ... 2018 2026 2020 2023 459
  1. Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia (2018)
    Daniel A. Pollyea, Brett M. Stevens et al. Nature Medicine

Immediate Impact

1 by Nobel laureates 9 from Science/Nature 56 standout
Sub-graph 1 of 21

Citing Papers

Past, present, and future of CRISPR genome editing technologies
2024 Standout
Cell death
2024 Standout
2 intermediate papers

Works of Austin E. Gillen being referenced

Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells
2020
Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia
2018 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Austin E. Gillen 1123 304 412 486 467 51 1.8k
Samirkumar B. Amin 1210 250 441 654 494 43 2.2k
Jeffrey A. Magee 1708 449 712 621 427 38 2.6k
Levi J. Beverly 1681 158 592 396 293 63 2.6k
Virginie Raynal 1084 287 550 678 459 40 2.3k
Charles E. de Bock 1072 125 397 413 230 66 1.9k
Tushar D. Bhagat 1460 158 441 684 395 55 2.3k
Craig April 929 266 239 501 196 41 1.7k
Jing Yang 1138 127 581 286 531 54 1.9k
Jae‐Seok Roe 1572 224 367 470 267 45 2.0k
Marc R. Mansour 1900 116 530 341 624 56 2.8k

All Works

Loading papers...

Rankless by CCL
2026